| Ellen Kielbasa, LCSW | |
|
87-680 Hakimo Rd, Waianae, HI 96792-3510 | |
| (808) 349-7540 | |
| Not Available |
| Full Name | Ellen Kielbasa |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 87-680 Hakimo Rd, Waianae, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053917161 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4584 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ellen Kielbasa, LCSW 87-680 Hakimo Rd, Waianae, HI 96792-3510 Ph: (808) 349-7540 | Ellen Kielbasa, LCSW 87-680 Hakimo Rd, Waianae, HI 96792-3510 Ph: (808) 349-7540 |
News Archive
An EU-funded project is using slime mold to produce accessible sensing devices with a wide range of applications, including environmental monitoring and health - helping European industry become more competitive in the growing biosensor device market.
Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.
Wako Diagnostics, a division of Wako Chemicals USA, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the uTASWako i30 instrument with alpha-fetoprotein L3 (AFP-L3) and des-gamma-carboxy prothrombin (DCP) in vitro diagnostic (IVD) tests in the USA.
University of Bath scientists have been awarded a research grant of £1.3 million to develop a portable device to detect the street drug ‘spice' on the spot. They expect the new technology to be ready for use in clinical settings, prisons and across police services within three years.
Preterm babies given the monoclonal antibody palivizumab to prevent respiratory syncytial virus (RSV) also appear less likely to develop recurrent wheeze, at least until the age of six, according to new research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Medicine.
› Verified 5 days ago
Ms. Sonya Louise Roundtree, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 84-265 Farrington Hwy Apt 415, Waianae, HI 96792 Phone: 808-990-4053 | |
George S Moises, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 87-908 Kulauku St, Waianae, HI 96792 Phone: 808-728-7346 | |
Alisa H. Au, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 87-2116 Farrington Hwy, Waianae, HI 96792 Phone: 808-432-3500 | |
Patricia Ann Johnson, LCSW, CSAC, MAC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 86-120 Farrington Hwy, A-107, Waianae, HI 96792 Phone: 808-292-8685 Fax: 808-696-5079 | |
Mrs. Betty J. Ha'o, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 85-888 Farrington Hwy, Waianae, HI 96792 Phone: 808-696-9498 Fax: 808-696-9403 | |
Jodi Kiilani Aiu Johnson, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 87-401 Manuaihue St, Waianae, HI 96792 Phone: 808-465-7352 |